Full Text View
Tabular View
No Study Results Posted
Related Studies
Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients
This study is currently recruiting participants.
Study NCT00844597   Information provided by AVI BioPharma, Inc.
First Received: December 24, 2008   Last Updated: August 12, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Duchenne Muscular Dystrophy
Additional conditions recognized in this trial
Muscular Dystrophies
Muscular Dystrophy, Duchenne
More general conditions related to this trial
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Muscular Diseases
Muscular Disorders, Atrophic
Musculoskeletal Diseases
Nervous System Diseases
Neuromuscular Diseases
Interventions listed in this trial
AVI-4658 for Injection
Sponsors listed in this trial
AVI BioPharma, Inc.
British Medical Research Council


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services